Central Nervous System

PV QA 2 - Poster Viewing Q&A 2

MO_10_2722 - Risk Factors for Early Cognitive Deterioration after Whole-Brain Radiation Therapy for Brain Metastasis

Monday, October 22
10:45 AM - 12:15 PM
Location: Innovation Hub, Exhibit Hall 3

Risk Factors for Early Cognitive Deterioration after Whole-Brain Radiation Therapy for Brain Metastasis
T. Nakano1, H. Saito1, K. Tanaka1, M. Shioi2, T. Oshikane1, K. Maruyama1, A. Ohta1, M. Kaidu1, E. Abe1, and H. Aoyama1; 1Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 2Department of Radiation Oncology, Niigata University Medical and Dental Hospital, Niigata, Japan

Purpose/Objective(s): To clarify clinical factors associated with early cognitive deterioration after WBRT for brain metastasis.

Materials/Methods: We administered a set of neurocognitive functioning tests (NFTs) to patients undergoing WBRT for brain metastasis in April 2012–March 2017. A total WBRT dose of 35 Gy/14 fractions, 30 Gy/10 fractions, or 25 Gy/10 fractions was delivered. Patient eligibility criteria: a Karnofsky Performance Status ≥60 and absence of severe neurological deficits that could interfere with the NFTs. The NFT set was: the Hopkins Verbal Learning Test-Revised (HVLT-R) total recall (TR), delayed recall (DR), and delayed recognition (DRecog) subdomains; the Trail Making Test (TMT) -A and -B subdomains; and the Controlled Oral Word Association (COWA). The NFTs were administered before WBRT (baseline) and at 4 and 8 months post-WBRT. We calculated each NFT's Z-score and compared the NFT's 4-month Z-score median to that at baseline. We divided the patients into two groups by relevant factors: age (<65 vs. ≥65 yrs), Graded Prognostic Assessment (GPA) pre-WBRT ( worse-GPA 0–1.5 vs. good GPA 2.0–4.0), intracranial tumor control at 4 months (intracranial progressive disease [PD] vs. non-PD), and the number of NFTs (8-month-complete group: the patients who completed the three planned examinations vs. 4-month-dropout group: those who underwent two examinations and then dropped out). The association between the deterioration of the 4-month Z-scores and the clinical factors was analyzed with the Wilcoxon signed-rank test. P-values <0.05 were considered significant.

Results: Consecutive 41 patients underwent the NFTs.Thirteen patients underwent the NFTs at 4 months but not at 8 months, due to death from primary cancer (n=8) or worsened general condition (n=5). In all 41 patients, there were significant declines in two items, TR (p=0.01) and DRecog (p=0.01). In the ≥65 yr-old group, there were significant declines in TR (p=0.01) and DRecog (p=0.02). The worse-GPA group showed significant declines in TR (p=0.02) and DRecog (p=0.04). In the intracranial PD group, four items demonstrated significant declines: TR (p<0.01), DR (p=0.02), DRecog (p<0.05), and COWA (p=0.04). The 4-month-dropout group showed significant declines in TR (p=0.02), DR (p=0.04), and DRecog (p=0.02). There were no significant 4-month declines in each corresponding counterpart.

Conclusion: The early cognitive deterioration after WBRT is related to age, estimated survival, intracranial tumor control, and the ability to continue undergoing NFTs.

Author Disclosure: T. Nakano: None. H. Saito: None. T. Oshikane: None. A. Ohta: None. E. Abe: None.

Toshimichi Nakano, MD

Presentation(s):

Send Email for Toshimichi Nakano


Assets

MO_10_2722 - Risk Factors for Early Cognitive Deterioration after Whole-Brain Radiation Therapy for Brain Metastasis



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Risk Factors for Early Cognitive Deterioration after Whole-Brain Radiation Therapy for Brain Metastasis